hydroxyurea has been researched along with Eosinophilia in 43 studies
Eosinophilia: Abnormal increase of EOSINOPHILS in the blood, tissues or organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 38-year-old man with idiopathic hypereosinophilic syndrome had an inadequate response to steroids and severe side effects from hydroxyurea treatment, which necessitated withdrawal of the treatment." | 7.68 | Successful long-term control of idiopathic hypereosinophilic syndrome with etoposide. ( de Vries, EG; Smit, AJ; van Essen, LH, 1991) |
| "In two of four patients with hypereosinophilia and Löffler's myocarditis (confirmed by biopsy) the activity of the disease was contained with prednisone, in one instance combined with hydroxycarbamide." | 7.67 | [Therapeutic possibilities in hypereosinophilia syndrome with Löffler's fibroplastic endomyocarditis. Efficacy of cytarabine and 6-thioguanine]. ( Bohn, T; Haas, R; Hunstein, W; Mundinger, A; Schaz, K, 1985) |
| " Although he was treated with prednisolone and hydroxyurea, marked eosinophilia persisted and lymphoblasts gradually increased in the bone marrow." | 4.78 | Hypereosinophilic syndrome evolving to acute lymphoblastic leukemia. ( Sanada, M; Takai, K, 1991) |
| " Before the appearance of CMML, he received a total dose of 2,894 mg of nimustine for the treatment of a pontine glioma over 12 years." | 3.69 | Therapy-related chronic myelomonocytic leukaemia with bone marrow eosinophilia associated with der(11)t(1;11)(q21;q14). ( Amemiya, Y; Hatake, K; Miura, Y; Miyata, T; Muroi, K; Saito, M, 1996) |
| "A 38-year-old man with idiopathic hypereosinophilic syndrome had an inadequate response to steroids and severe side effects from hydroxyurea treatment, which necessitated withdrawal of the treatment." | 3.68 | Successful long-term control of idiopathic hypereosinophilic syndrome with etoposide. ( de Vries, EG; Smit, AJ; van Essen, LH, 1991) |
| "In two of four patients with hypereosinophilia and Löffler's myocarditis (confirmed by biopsy) the activity of the disease was contained with prednisone, in one instance combined with hydroxycarbamide." | 3.67 | [Therapeutic possibilities in hypereosinophilia syndrome with Löffler's fibroplastic endomyocarditis. Efficacy of cytarabine and 6-thioguanine]. ( Bohn, T; Haas, R; Hunstein, W; Mundinger, A; Schaz, K, 1985) |
| "Hypereosinophilia has generally been defined as a peripheral blood eosinophil count greater than 1,500/mm(3) and may be associated with tissue damage." | 2.52 | World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management. ( Gotlib, J, 2015) |
| "Myelodysplastic syndrome with chromosomal translocation t(5;12)(q31-33;p12-13) and eosinophilia is a new entity recently described." | 2.39 | Myelodysplastic syndrome with t(5;12)(q31;p12-p13) and eosinophilia: a pediatric case with review of literature. ( Baranger, L; Blanchet, O; François, S; Ifrah, N; Larget-Piet, L; Le Moine, PJ; Pellier, I; Rialland, X, 1996) |
| "Significant blood eosinophilia is uncommon in leiomyomas and should raise suspicion of malignant etiology for a pelvic mass." | 1.37 | Metastatic uterine leiomyosarcoma and eosinophilia. ( Cheung, WY; Ksienski, D, 2011) |
| "A 60-year-old white woman with polycythemia rubra vera post splenectomy in November 2001 was found to have peripheral white blood cell counts increasing over 3 months." | 1.32 | Paraneoplastic eosinophilic fasciitis: a case report. ( Cohen, JJ; Jacob, SE; Kirsner, RS; Lodha, R; Romanelli, P, 2003) |
| "Hypereosinophilic syndrome was diagnosed." | 1.31 | Successful treatment of hypereosinophilic syndrome in a dog. ( Perkins, M; Watson, A, 2001) |
| "In our patient the occurrence of a plasmocytoma with a dramatic course leads to suspect an underlying complex genetic aberration." | 1.27 | Hypereosinophilic syndrome and plasmocytoma. Report of a case and review of the literature. ( Bosman, C; Calvieri, S; Carfagna, GF; De Rosa, F; Franchi, F; Seminara, P, 1984) |
| "Treatment with hydroxyurea was followed by a dramatic response of both the polycythemia vera and the HES, with return to normal of the abnormal immunologic measures." | 1.27 | Hypereosinophilic syndrome associated with polycythemia vera. ( Berrebi, A; Varon, D; Wetzler, M, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (44.19) | 18.7374 |
| 1990's | 14 (32.56) | 18.2507 |
| 2000's | 5 (11.63) | 29.6817 |
| 2010's | 4 (9.30) | 24.3611 |
| 2020's | 1 (2.33) | 2.80 |
| Authors | Studies |
|---|---|
| Shomali, W | 1 |
| Gotlib, J | 3 |
| Liu, AY | 1 |
| Lowe, RC | 1 |
| Levy, BD | 1 |
| Katz, JT | 1 |
| Loscalzo, J | 1 |
| Ksienski, D | 1 |
| Cheung, WY | 1 |
| Jacob, SE | 1 |
| Lodha, R | 1 |
| Cohen, JJ | 1 |
| Romanelli, P | 1 |
| Kirsner, RS | 1 |
| Borbényi, Z | 1 |
| Charlanne, H | 1 |
| Prin, L | 2 |
| Franchi, F | 1 |
| De Rosa, F | 1 |
| Seminara, P | 1 |
| Calvieri, S | 1 |
| Carfagna, GF | 1 |
| Bosman, C | 1 |
| Spry, CJ | 1 |
| Eakin, DL | 1 |
| Gill, DP | 1 |
| Weiss, GB | 1 |
| Farcet, JP | 1 |
| Binaghi, M | 1 |
| Kuentz, M | 1 |
| Merlier, JF | 1 |
| Mayaud, C | 1 |
| Nebout, T | 1 |
| Nass, P | 1 |
| Ferret, J | 1 |
| Flaum, MA | 2 |
| Schooley, RT | 2 |
| Fauci, AS | 4 |
| Gralnick, HR | 2 |
| Efira, A | 1 |
| Waterlot, Y | 1 |
| DeSimone, PA | 1 |
| Inhorn, RC | 1 |
| Aster, JC | 1 |
| Roach, SA | 1 |
| Slapak, CA | 1 |
| Soiffer, R | 1 |
| Tantravahi, R | 1 |
| Stone, RM | 1 |
| Howell, RE | 1 |
| Sickels, BD | 1 |
| Woeppel, SL | 1 |
| Jenkins, LP | 1 |
| Rubin, EB | 1 |
| Weichman, BM | 1 |
| Coutant, G | 1 |
| Blétry, O | 1 |
| Hauteville, D | 1 |
| de Puyfontaine, O | 1 |
| Abgrall, JF | 1 |
| Godeau, P | 1 |
| Muir, P | 1 |
| Gruffydd-Jones, TJ | 1 |
| Brown, PJ | 1 |
| Koike, M | 1 |
| Ishiyama, T | 1 |
| Pellier, I | 1 |
| Le Moine, PJ | 1 |
| Rialland, X | 1 |
| François, S | 1 |
| Baranger, L | 1 |
| Blanchet, O | 1 |
| Larget-Piet, L | 1 |
| Ifrah, N | 1 |
| Muroi, K | 1 |
| Miyata, T | 1 |
| Saito, M | 1 |
| Hatake, K | 1 |
| Amemiya, Y | 1 |
| Miura, Y | 1 |
| Rimbrot, S | 1 |
| Bennett, M | 1 |
| Komorovski, M | 1 |
| Levy, Y | 1 |
| Perkins, M | 1 |
| Watson, A | 1 |
| Parrillo, JE | 2 |
| Wolff, SM | 2 |
| Solley, GO | 1 |
| Maldonado, JE | 1 |
| Gleich, GJ | 2 |
| Giuliani, ER | 1 |
| Hoagland, HC | 1 |
| Pierre, RV | 1 |
| Brown, AL | 1 |
| Straetmans, N | 1 |
| Ferrant, A | 1 |
| Martiat, P | 1 |
| Sokal, G | 1 |
| Michaux, JL | 1 |
| Lefebvre, P | 1 |
| Blondel, S | 1 |
| Lardinois, J | 1 |
| Gilbert, P | 1 |
| Hillyer, MH | 1 |
| Mair, TS | 1 |
| Takai, K | 1 |
| Sanada, M | 1 |
| Smit, AJ | 1 |
| van Essen, LH | 1 |
| de Vries, EG | 1 |
| Zielinski, RM | 1 |
| Lawrence, WD | 1 |
| Murphy, PT | 1 |
| Fennelly, DF | 1 |
| Stuart, M | 1 |
| O'Donnell, JR | 1 |
| Fischer, TJ | 1 |
| Daugherty, C | 1 |
| Gushurst, C | 1 |
| Kephart, GM | 1 |
| Shah, AM | 1 |
| Joglekar, M | 1 |
| Nadal, D | 1 |
| Plüss, HJ | 1 |
| Jörg, W | 1 |
| Hitzig, WH | 1 |
| Wynn, SR | 1 |
| Sachs, MI | 1 |
| Keating, MU | 1 |
| Ostrom, NK | 1 |
| Kadota, RP | 1 |
| O'Connell, EJ | 1 |
| Smithson, WA | 1 |
| Varon, D | 1 |
| Wetzler, M | 1 |
| Berrebi, A | 1 |
| Maréchaud, R | 1 |
| Neau, JP | 1 |
| Quéron, B | 1 |
| Lessard, M | 1 |
| Babin, P | 1 |
| Lefevre, JP | 1 |
| Sudre, Y | 1 |
| Haas, R | 1 |
| Mundinger, A | 1 |
| Bohn, T | 1 |
| Schaz, K | 1 |
| Hunstein, W | 1 |
| Mercadanti, M | 1 |
| Cavalieri, F | 1 |
| Ferraccioli, GF | 1 |
| Ambanelli, U | 1 |
11 reviews available for hydroxyurea and Eosinophilia
| Article | Year |
|---|---|
World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Bone Marrow Examination; Clone Cells; Disease Manage | 2014 |
World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antineoplastic Agents; Disease Management; Eosinoph | 2015 |
[Disorders with eosinophilia, treatment of hypereosinophilic syndrome].
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Decision Trees; Eosinophilia; Glucocorti | 2005 |
[Treatment of hypereosinophilia].
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Benzam | 2006 |
The hypereosinophilic syndrome: clinical features, laboratory findings and treatment.
Topics: Anticoagulants; Bone Marrow; Central Nervous System Diseases; Endomyocardial Fibrosis; Eosinophilia; | 1982 |
A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Prot | 1995 |
[Treatment of hypereosinophilic syndromes of myeloproliferative expression with the combination of hydroxyurea and interferon alpha. Apropos of 7 cases].
Topics: Adult; Drug Therapy, Combination; Eosinophilia; Female; Humans; Hydroxyurea; Interferon-alpha; Male; | 1993 |
[Hypereosinophilic syndrome].
Topics: Adult; Aged; Cardiovascular Diseases; Eosinophilia; Female; Humans; Hydroxyurea; Leukemia, Eosinophi | 1993 |
Myelodysplastic syndrome with t(5;12)(q31;p12-p13) and eosinophilia: a pediatric case with review of literature.
Topics: Adult; Child; Chromosome Mapping; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 5; Eosinophi | 1996 |
[Hypereosinophilia syndrome. Apropos of 2 cases and literature review].
Topics: Aged; Cardiomyopathy, Restrictive; Eosinophilia; Humans; Hydroxyurea; Interferon-alpha; Male; Middle | 1992 |
Hypereosinophilic syndrome evolving to acute lymphoblastic leukemia.
Topics: Adult; Blood Proteins; Endocardium; Endomyocardial Fibrosis; Eosinophil Granule Proteins; Eosinophil | 1991 |
32 other studies available for hydroxyurea and Eosinophilia
| Article | Year |
|---|---|
World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Disease Management; Eosinophilia; Eosino | 2022 |
Clinical problem-solving. A rash hypothesis.
Topics: Adult; Biopsy; Blood Cell Count; Bone Marrow; Colon; Diagnosis, Differential; Diarrhea; Drug Therapy | 2010 |
Metastatic uterine leiomyosarcoma and eosinophilia.
Topics: Antineoplastic Agents; Benzamides; Dyspnea; Eosinophilia; Fatal Outcome; Female; Humans; Hydroxyurea | 2011 |
Paraneoplastic eosinophilic fasciitis: a case report.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Eosinophilia; Fasciitis; Female; Humans; Hydroxyure | 2003 |
Hypereosinophilic syndrome and plasmocytoma. Report of a case and review of the literature.
Topics: Eosinophilia; Eosinophils; Humans; Hydroxyurea; Immunoglobulin lambda-Chains; Immunoglobulin Light C | 1984 |
Response of hypereosinophilic syndrome to 6-thioguanine and cytarabine.
Topics: Adult; Cytarabine; Eosinophilia; Heart Failure; Humans; Hydroxyurea; Male; Prednisone; Syndrome; Thi | 1982 |
A hypereosinophilic syndrome with retinal arteritis and tuberculosis.
Topics: Adult; Arteritis; Cardiomyopathies; Eosinophilia; Fluorescein Angiography; Humans; Hydroxyurea; Male | 1982 |
A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. I. Hematologic manifestations.
Topics: Bone Marrow; Busulfan; Cyclophosphamide; Dose-Response Relationship, Drug; Eosinophilia; Eosinophils | 1981 |
A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. II. Clinical manifestations.
Topics: Adolescent; Adult; Aged; Child; Cyclophosphamide; Eosinophilia; Heart Diseases; Humans; Hydroxyurea; | 1981 |
[Hypereosinophilia (author's transl)].
Topics: Adult; Electrocardiography; Eosinophilia; Female; Hemiplegia; Humans; Hydroxyurea; Male; Middle Aged | 1981 |
Grand rounds. Hypereosinophilic syndrome: a review of clinical manifestations and therapy.
Topics: Adrenal Cortex Hormones; Eosinophilia; Humans; Hydroxyurea; Syndrome | 1980 |
Leukotrienes mediate antigen-induced airway hyper-reactivity in guinea pigs.
Topics: Acetophenones; Animals; Antigens; Bronchoconstriction; Eosinophilia; Guinea Pigs; Hydroxyurea; Indol | 1994 |
Hypereosinophilic syndrome in a cat.
Topics: Animals; Cat Diseases; Cats; Eosinophilia; Eosinophils; Hydroxyurea; Lymph Nodes; Lymphatic Diseases | 1993 |
Therapy-related chronic myelomonocytic leukaemia with bone marrow eosinophilia associated with der(11)t(1;11)(q21;q14).
Topics: Antineoplastic Agents; Bone Marrow; Brain Neoplasms; Child; Chromosome Aberrations; Eosinophilia; Fa | 1996 |
[Eosinophilic ascites as a presenting symptom of the hypereosinophilic syndrome].
Topics: Adult; Ascitic Fluid; Asthma; Diagnosis, Differential; Eosinophilia; Humans; Hydroxyurea; Hypereosin | 2001 |
Successful treatment of hypereosinophilic syndrome in a dog.
Topics: Animals; Anti-Inflammatory Agents; Dog Diseases; Dogs; Enzyme Inhibitors; Eosinophilia; Female; Hydr | 2001 |
The hypereosinophilic syndrome: dramatic response to therapeutic intervention.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Eosinophilia; Female; Humans; Hydroxyurea; Male; M | 1977 |
Therapy of the hypereosinophilic syndrome.
Topics: Adolescent; Adult; Aged; Bone Marrow Diseases; Child; Child, Preschool; Eosinophilia; Female; Humans | 1978 |
Endomyocardiopathy with eosinophilia.
Topics: Adolescent; Adult; Busulfan; Cardiomyopathies; Cytoplasmic Granules; Digoxin; Diphenhydramine; Eosin | 1976 |
[Interpreting hypereosinophilia].
Topics: Adrenal Cortex Hormones; Clinical Laboratory Techniques; Diagnosis, Differential; Echocardiography; | 1992 |
Multisystemic eosinophilic epitheliotropic disease in a horse: attempted treatment with hydroxyurea and dexamethasone.
Topics: Animals; Dexamethasone; Eosinophilia; Epithelium; Female; Gastrointestinal Diseases; Horse Diseases; | 1992 |
Successful long-term control of idiopathic hypereosinophilic syndrome with etoposide.
Topics: Adult; Cardiomegaly; Eosinophilia; Etoposide; Humans; Hydroxyurea; Male; Syndrome; Thrombocytopenia | 1991 |
Interferon-alpha for the hypereosinophilic syndrome.
Topics: Adult; Eosinophilia; Humans; Hydroxyurea; Interferon Type I; Leukocyte Count; Male; Prednisone; Synd | 1990 |
Alfa-interferon in a case of hypereosinophilic syndrome.
Topics: Adult; Eosinophilia; Humans; Hydroxyurea; Interferon alpha-2; Interferon-alpha; Male; Prednisolone; | 1990 |
Systemic vasculitis associated with eosinophilia and marked degranulation of tissue eosinophils.
Topics: Blood Proteins; Child; Diagnosis, Differential; Eosinophil Granule Proteins; Eosinophilia; Eosinophi | 1988 |
Eosinophilic colitis as a complication of the hypereosinophilic syndrome.
Topics: Adult; Colitis; Eosinophilia; Female; Humans; Hydroxyurea; Syndrome | 1987 |
[Hypereosinophilic syndrome in acute lymphatic leukemia].
Topics: Child, Preschool; Diagnosis, Differential; Eosinophilia; Humans; Hydroxyurea; Leukemia, Lymphoid; Ma | 1986 |
Idiopathic hypereosinophilic syndrome in a 5 1/2-month-old infant.
Topics: Drug Therapy, Combination; Eosinophilia; Humans; Hydroxyurea; Infant; Leukocyte Count; Male; Prednis | 1987 |
Hypereosinophilic syndrome associated with polycythemia vera.
Topics: Eosinophilia; Female; Humans; Hydroxyurea; Middle Aged; Polycythemia Vera; Primary Myelofibrosis; Re | 1986 |
[Hypereosinophilic syndrome: a new case of myeloproliferative type].
Topics: Blood Cell Count; Eosinophilia; Follow-Up Studies; Humans; Hydroxyurea; Male; Middle Aged; Myeloprol | 1985 |
[Therapeutic possibilities in hypereosinophilia syndrome with Löffler's fibroplastic endomyocarditis. Efficacy of cytarabine and 6-thioguanine].
Topics: Adult; Cytarabine; Endocarditis; Eosinophilia; Female; Humans; Hydroxyurea; Male; Middle Aged; Predn | 1985 |
[Idiopathic hypereosinophilic syndrome. Current clinico-therapeutic state].
Topics: Adrenal Cortex Hormones; Adult; Antibody Formation; Anticoagulants; Blood Proteins; Cardiomyopathies | 1985 |